STK25

Chr 2

serine/threonine kinase 25

Also known as: SOK1, YSK1

STK25 encodes an oxidant stress-activated serine/threonine kinase that regulates protein transport at the Golgi apparatus, cell polarity, and migration, and functions as part of STRIPAK complexes that control multiple signaling pathways including Hippo, MAPK, and cytoskeleton remodeling. Mutations cause autosomal recessive primary microcephaly with seizures and intellectual disability. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.533), suggesting some tolerance to reduced gene dosage.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
7
Pubs (1 yr)
107
P/LP submissions
0%
P/LP missense
0.53
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySTK25
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.28) despite low pLI — interpret in context.
📋
ClinVar Variants
105 unique Pathogenic / Likely Pathogenic· 92 VUS of 216 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.53LOEUF
pLI 0.052
Z-score 3.29
OE 0.28 (0.160.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
2.23Z-score
OE missense 0.62 (0.550.70)
171 obs / 275.3 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.28 (0.160.53)
00.351.4
Missense OE0.62 (0.550.70)
00.61.4
Synonymous OE1.04
01.21.6
LoF obs/exp: 7 / 24.6Missense obs/exp: 171 / 275.3Syn Z: -0.31
DN
0.74top 25%
GOF
0.6735th %ile
LOF
0.3356th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

216 submitted variants in ClinVar

Classification Summary

Pathogenic92
Likely Pathogenic13
VUS92
Likely Benign4
92
Pathogenic
13
Likely Pathogenic
92
VUS
4
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
92
0
92
Likely Pathogenic
0
0
13
0
13
VUS
0
77
15
0
92
Likely Benign
0
1
0
3
4
Benign
0
0
0
0
0
Total0781203201

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

STK25 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC